Related Experiment Video
Updated: Jul 1, 2025

Isolation and Kv Channel Recordings in Murine Atrial and Ventricular Cardiomyocytes
Published on: March 12, 2013
Reduced kinase function in two ultra-rare TNNI3K variants in families with congenital junctional ectopic tachycardia
Caroline Pham1,2, Tamara T Koopmann3,4, Jeffrey M Vinocur5
1Department of Experimental Cardiology Heart Center, Amsterdam UMC Location University of Amsterdam, Amsterdam, The Netherlands.
Abstract:
Genetic missense variants in TNNI3K, encoding troponin-I interacting kinase, have been associated with dilated cardiomyopathy (DCM) and observed in families with supraventricular tachycardias (SVT). Previously, a family harboring the TNNI3K-c.1615A > G (p.Thr539Ala) variant presented with congenital junctional ectopic tachycardia (CJET), an arrhythmia that arises from the atrioventricular (AV) node and His bundle. However, this was a relatively small four-generational family with limited genetic testing (N = 3). We here describe a multigenerational family with CJET harboring a novel ultra-rare TNNI3K variant: TNNI3K-c.1729C > T (p.Leu577Phe). Of all 18 variant carriers, 13 individuals presented with CJET, resulting in a genetic penetrance of 72%. In addition, CJET is reported in another small family harboring TNNI3K-c.2225C > T (p.Pro742Leu). Similar to the previously published CJET family, both TNNI3K variants demonstrate a substantial reduction of kinase activity. Our study contributes novel evidence supporting the involvement of TNNI3K genetic variants as significant contributors to CJET, shedding light on potential mechanisms underlying this cardiac arrhythmia.
More Related Videos
Related Concept Videos
Receptor Tyrosine Kinases
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Tight Junctions
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:

